ICS/LABA before and after switch. حسب Rieko Kondo (10010647)

الموضوعات:

Diseases excluded from the analysis. حسب Rieko Kondo (10010647)

الموضوعات:

Points of convergence / divergence between qualitative and quantitative findings. حسب Emma Murphy (2270992)

الموضوعات:

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations حسب Hui Li (32376)

الموضوعات:

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations حسب Hui Li (32376)

الموضوعات:

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations حسب Hui Li (32376)

الموضوعات:

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations حسب Hui Li (32376)

الموضوعات:

Chemicals that decrease the expression levels of significant TWAS genes negatively associated with UF. حسب Gayeon Kim (671557)

Sampling point (Source: حسب Yonggang Huang (223155)

The Laboratory Animal Flow Diagram. حسب Xueqin lu (22250795)

الموضوعات:

¹H NMR spectra for kylo-0603. حسب Xueqin lu (22250795)

الموضوعات:

¹³C NMR spectra for Kylo-0603. حسب Xueqin lu (22250795)

الموضوعات:

The structures of T3 and Kylo-0603. حسب Xueqin lu (22250795)

الموضوعات:

Synthesis process of Kylo-0603. حسب Xueqin lu (22250795)

الموضوعات:

ESI-HRMS spectra for Kylo-0603. حسب Xueqin lu (22250795)

الموضوعات:

Intraoperative anesthetics administered by group. حسب Adeel A. Faruki (13839691)

الموضوعات:

Fig 3 - حسب Adeel A. Faruki (13839691)

الموضوعات:

Postoperative outcomes. حسب Adeel A. Faruki (13839691)

الموضوعات:

Preoperative characteristics. حسب Adeel A. Faruki (13839691)

الموضوعات:

Consolidated Standards of Reporting Trials (CONSORT) flow diagram. حسب Adeel A. Faruki (13839691)

الموضوعات: